Jill A. Howe - Mar 7, 2024 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Chief Financial Officer
Signature
/s/ Jill A. Howe
Stock symbol
LCTX
Transactions as of
Mar 7, 2024
Transactions value $
$0
Form type
4
Date filed
3/8/2024, 04:05 PM
Previous filing
Jun 16, 2023
Next filing
Jun 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Employee Stock Option (Right to Buy) Award $0 +650K $0.00 650K Mar 7, 2024 Common Shares 650K $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.